Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr₹1,134 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,177 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr
Mar2020₹1,134 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr
21.33
Mar2020 ₹1,134 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,459.2 Cr -2.8% -13.4% 59.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.7% 0.9% 34.7% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -1.1% 1.1% 57.7% Stock Analytics
CIPLA ₹114,019.0 Cr 0.6% -1.7% 8.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -1.6% -4.6% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -0.5% 2.5% 36% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.8%

-13.4%

59.8%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses